{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:00:57Z","timestamp":1784768457240,"version":"3.55.0"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM103446"],"award-info":[{"award-number":["P20 GM103446"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2 BX005061"],"award-info":[{"award-number":["IK2 BX005061"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The lymphatic system maintains physiological homeostasis through constant immunosurveillance, immune cell trafficking, and regulation of interstitial fluid flow. Lymphatic dysfunction is associated with a wide range of pathologies, including cancer metastasis and lymphedema. Aberrant lymphatic structure also contributes to chronic wounds and transplanted organ rejection. These functional and structural deficits have inspired strategies for lymphatic vasculature modulation and tissue engineering to regulate immune functions during disease and injury rehabilitation. Lymphangiogenesis\u2014the process of lymphatic vessel growth\u2014 is central to the success of these strategies and has broad potential if harnessed for therapeutic intervention and tissue integration. Here we review the opportunities and obstacles for biomolecular pathway modulation, nanotechnology, and tissue engineering to promote or inhibit lymphangiogenesis.<\/jats:p>","DOI":"10.1038\/s41536-026-00472-z","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:04:57Z","timestamp":1778598297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventions and platforms that direct lymphangiogenesis to restore physiological homeostasis and enhance immunoregulation"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0803-3022","authenticated-orcid":false,"given":"Lauren G.","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2073-7899","authenticated-orcid":false,"given":"Mikayla S.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-6488","authenticated-orcid":false,"given":"Robert S.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"472_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","volume":"182","author":"G Oliver","year":"2020","unstructured":"Oliver, G., Kipnis, J., Randolph, G. J. & Harvey, N. L. The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease. Cell 182, 270\u2013296 (2020).","journal-title":"Cell"},{"key":"472_CR2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2308511120","volume":"120","author":"R Sender","year":"2023","unstructured":"Sender, R. et al. The total mass, number, and distribution of immune cells in the human body. Proc. Natl. Acad. Sci. USA 120, e2308511120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR3","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen, A. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566\u20133570 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov, V. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290\u2013298 (1996).","journal-title":"EMBO J."},{"key":"472_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen, M. G. et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95, 548\u2013553 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1083\/jcb.144.4.789","volume":"144","author":"S Banerji","year":"1999","unstructured":"Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789\u2013801 (1999).","journal-title":"J. Cell Biol."},{"key":"472_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0092-8674(00)81511-1","volume":"98","author":"JT Wigle","year":"1999","unstructured":"Wigle, J. T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769\u2013778 (1999).","journal-title":"Cell"},{"key":"472_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo, K. The lymphatic vasculature in disease. Nat. Med. 17, 1371\u20131380 (2011).","journal-title":"Nat. Med."},{"key":"472_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tem.2010.04.003","volume":"21","author":"JB Dixon","year":"2010","unstructured":"Dixon, J. B. Lymphatic lipid transport: sewer or subway? Trends Endocrinol. Metab. 21, 480\u2013487 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"472_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41569-018-0087-8","volume":"16","author":"E Brakenhielm","year":"2019","unstructured":"Brakenhielm, E. & Alitalo, K. Cardiac lymphatics in health and disease. Nat. Rev. Cardiol. 16, 56\u201368 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"472_CR11","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1084\/jem.20091739","volume":"206","author":"H Pflicke","year":"2009","unstructured":"Pflicke, H. & Sixt, M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206, 2925\u20132935 (2009).","journal-title":"J. Exp. Med."},{"key":"472_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1084\/jem.20062596","volume":"204","author":"P Baluk","year":"2007","unstructured":"Baluk, P. et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204, 2349\u20132362 (2007).","journal-title":"J. Exp. Med."},{"key":"472_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2353\/ajpath.2008.080101","volume":"173","author":"N Wick","year":"2008","unstructured":"Wick, N. et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin-low, CCL27-expressing lymphatic endothelial cells. Am. J. Pathol. 173, 1202\u20131209 (2008).","journal-title":"Am. J. Pathol."},{"key":"472_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-immunol-041015-055354","volume":"35","author":"GJ Randolph","year":"2017","unstructured":"Randolph, G. J., Ivanov, S., Zinselmeyer, B. H. & Scallan, J. P. The lymphatic system: integral roles in immunity. Annu. Rev. Immunol. 35, 31\u201352 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"472_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62799-x","volume":"10","author":"MS Razavi","year":"2020","unstructured":"Razavi, M. S., Leonard-Duke, J., Hardie, B., Dixon, J. B. & Gleason, R. L. Axial stretch regulates rat tail collecting lymphatic vessel contractions. Sci. Rep. 10, 5918 (2020).","journal-title":"Sci. Rep."},{"key":"472_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/joa.13167","volume":"236","author":"LA O\u2019Hagan","year":"2020","unstructured":"O\u2019Hagan, L. A. et al. Anatomy of the lymphovenous valve of the thoracic duct in humans. J. Anat. 236, 1146\u20131153 (2020).","journal-title":"J. Anat."},{"key":"472_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.exer.2004.06.028","volume":"79","author":"P Hamrah","year":"2004","unstructured":"Hamrah, P. et al. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp. Eye Res. 79, 553\u2013561 (2004).","journal-title":"Exp. Eye Res."},{"key":"472_CR18","doi-asserted-by":"publisher","first-page":"1527971","DOI":"10.3389\/fcell.2025.1527971","volume":"13","author":"KG Kuonqui","year":"2025","unstructured":"Kuonqui, K. G. et al. Regulation of VEGFR3 signaling in lymphatic endothelial cells. Front. Cell Dev. Biol. 13, 1527971 (2025).","journal-title":"Front. Cell Dev. Biol."},{"key":"472_CR19","doi-asserted-by":"publisher","first-page":"e39558","DOI":"10.1371\/journal.pone.0039558","volume":"7","author":"S Coso","year":"2012","unstructured":"Coso, S., Zeng, Y., Opeskin, K. & Williams, E. D. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis. PLoS ONE 7, e39558 (2012).","journal-title":"PLoS ONE"},{"key":"472_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.matbio.2018.02.001","volume":"78\u201379","author":"DG Jackson","year":"2019","unstructured":"Jackson, D. G. Hyaluronan in the lymphatics: the key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking. Matrix Biol. 78\u201379, 219\u2013235 (2019).","journal-title":"Matrix Biol."},{"key":"472_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0002-9440(10)65285-6","volume":"154","author":"S Breiteneder-Geleff","year":"1999","unstructured":"Breiteneder-Geleff, S. et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Am. J. Pathol. 154, 385\u2013394 (1999).","journal-title":"Am. J. Pathol."},{"key":"472_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1101\/gad.1859310","volume":"24","author":"RS Srinivasan","year":"2010","unstructured":"Srinivasan, R. S. et al. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 24, 696\u2013707 (2010).","journal-title":"Genes Dev."},{"key":"472_CR23","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1101\/gad.216226.113","volume":"28","author":"RS Srinivasan","year":"2014","unstructured":"Srinivasan, R. S. et al. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 28, 2175\u20132187 (2014).","journal-title":"Genes Dev."},{"key":"472_CR24","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1172\/JCI82045","volume":"125","author":"J Bernier-Latmani","year":"2015","unstructured":"Bernier-Latmani, J. et al. DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport. J. Clin. Investig. 125, 4572\u20134586 (2015).","journal-title":"J. Clin. Investig."},{"key":"472_CR25","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1210\/en.2010-0629","volume":"151","author":"HM Brown","year":"2010","unstructured":"Brown, H. M., Robker, R. L. & Russell, D. L. Development and hormonal regulation of the ovarian lymphatic vasculature. Endocrinology 151, 5446\u20135455 (2010).","journal-title":"Endocrinology"},{"key":"472_CR26","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/humrep\/dem037","volume":"22","author":"JF Donoghue","year":"2007","unstructured":"Donoghue, J. F., Lederman, F. L., Susil, B. J. & Rogers, P. A. W. Lymphangiogensis of normal endometrium and endometrial adenocarcinoma. Hum. Reprod. 22, 1705\u20131713 (2007).","journal-title":"Hum. Reprod."},{"key":"472_CR27","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","volume":"16","author":"V Joukov","year":"1997","unstructured":"Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898\u20133911 (1997).","journal-title":"EMBO J."},{"key":"472_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74\u201380 (2004).","journal-title":"Nat. Immunol."},{"key":"472_CR29","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/MCB.25.6.2441-2449.2005","volume":"25","author":"ME Baldwin","year":"2005","unstructured":"Baldwin, M. E. et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell. Biol. 25, 2441\u20132449 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"472_CR30","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1096\/fj.05-5646com","volume":"20","author":"T Karpanen","year":"2006","unstructured":"Karpanen, T. et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462\u20131472 (2006).","journal-title":"FASEB J."},{"key":"472_CR31","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1242\/dev.129.20.4797","volume":"129","author":"L Yuan","year":"2002","unstructured":"Yuan, L. et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797\u20134806 (2002).","journal-title":"Development"},{"key":"472_CR32","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1158\/1078-0432.CCR-12-0708","volume":"18","author":"W Zhuo","year":"2012","unstructured":"Zhuo, W. et al. The CXCL12\u2013CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Clin. Cancer Res. 18, 5387\u20135398 (2012).","journal-title":"Clin. Cancer Res."},{"key":"472_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","volume":"3","author":"NW Gale","year":"2002","unstructured":"Gale, N. W. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell 3, 411\u2013423 (2002).","journal-title":"Dev. Cell"},{"key":"472_CR34","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1182\/blood-2004-08-3382","volume":"105","author":"T Morisada","year":"2005","unstructured":"Morisada, T. et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105, 4649\u20134656 (2005).","journal-title":"Blood"},{"key":"472_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-8-10","volume":"8","author":"VP Nguyen","year":"2007","unstructured":"Nguyen, V. P. et al. Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. BMC Cell Biol. 8, 10 (2007).","journal-title":"BMC Cell Biol."},{"key":"472_CR36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1242\/dev.043380","volume":"137","author":"X Qu","year":"2010","unstructured":"Qu, X., Tompkins, K., Batts, L. E., Puri, M. & Baldwin, H. S. Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Development 137, 1285\u20131295 (2010).","journal-title":"Development"},{"key":"472_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/ATVBAHA.109.196618","volume":"30","author":"G D\u2019Amico","year":"2010","unstructured":"D\u2019Amico, G. et al. Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. ATVB 30, 207\u2013209 (2010).","journal-title":"ATVB"},{"key":"472_CR38","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1253\/circj.CJ-09-0666","volume":"73","author":"N Mochizuki","year":"2009","unstructured":"Mochizuki, N. Vascular integrity mediated by vascular endothelial cadherin and regulated by sphingosine 1-phosphate and angiopoietin-1. Circ. J. 73, 2183\u20132191 (2009).","journal-title":"Circ. J."},{"key":"472_CR39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1182\/blood-2007-11-125203","volume":"112","author":"CM Yoon","year":"2008","unstructured":"Yoon, C. M. et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1\/Gi\/PLC\/Ca2+ signaling pathways. Blood 112, 1129\u20131138 (2008).","journal-title":"Blood"},{"key":"472_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/ATVBAHA.108.172676","volume":"29","author":"C Jang","year":"2009","unstructured":"Jang, C. et al. Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. ATVB 29, 401\u2013407 (2009).","journal-title":"ATVB"},{"key":"472_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1172\/JCI71603","volume":"124","author":"W Zheng","year":"2014","unstructured":"Zheng, W., Aspelund, A. & Alitalo, K. Lymphangiogenic factors, mechanisms, and applications. J. Clin. Investig. 124, 878\u2013887 (2014).","journal-title":"J. Clin. Investig."},{"key":"472_CR42","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/cancers15041169","volume":"15","author":"H Deng","year":"2023","unstructured":"Deng, H. et al. Current status of lymphangiogenesis: molecular mechanism, immune tolerance, and application prospect. Cancers 15, 1169 (2023).","journal-title":"Cancers"},{"key":"472_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature21028","volume":"542","author":"BW Wong","year":"2017","unstructured":"Wong, B. W. et al. The role of fatty acid \u03b2-oxidation in lymphangiogenesis. Nature 542, 49\u201354 (2017).","journal-title":"Nature"},{"key":"472_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30490-6","volume":"13","author":"O Me\u00e7e","year":"2022","unstructured":"Me\u00e7e, O. et al. Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis. Nat. Commun. 13, 2760 (2022).","journal-title":"Nat. Commun."},{"key":"472_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe7359","volume":"7","author":"W Ma","year":"2021","unstructured":"Ma, W. et al. Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance. Sci. Adv. 7, eabe7359 (2021).","journal-title":"Sci. Adv."},{"key":"472_CR46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s42255-019-0087-y","volume":"1","author":"M Garc\u00eda-Caballero","year":"2019","unstructured":"Garc\u00eda-Caballero, M. et al. Role and therapeutic potential of dietary ketone bodies in lymph vessel growth. Nat. Metab. 1, 666\u2013675 (2019).","journal-title":"Nat. Metab."},{"key":"472_CR47","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.devcel.2025.04.012","volume":"60","author":"F Han","year":"2025","unstructured":"Han, F. et al. Lymphatic endothelial mTORC1 instructs metabolic and developmental signaling during lymphangiogenesis. Dev. Cell 60, 2331\u20132347.e6 (2025).","journal-title":"Dev. Cell"},{"key":"472_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/emboj.2011.456","volume":"31","author":"L Planas-Paz","year":"2012","unstructured":"Planas-Paz, L. et al. Mechanoinduction of lymph vessel expansion. EMBO J. 31, 788\u2013804 (2012).","journal-title":"EMBO J."},{"key":"472_CR49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCRESAHA.109.207274","volume":"106","author":"DO Miteva","year":"2010","unstructured":"Miteva, D. O. et al. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ.Res. 106, 920\u2013931 (2010).","journal-title":"Circ.Res."},{"key":"472_CR50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1083\/jcb.201408103","volume":"208","author":"BG Coon","year":"2015","unstructured":"Coon, B. G. et al. Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex. J. Cell Biol. 208, 975\u2013986 (2015).","journal-title":"J. Cell Biol."},{"key":"472_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04645","volume":"4","author":"N Baeyens","year":"2015","unstructured":"Baeyens, N. et al. Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point. eLife 4, e04645 (2015).","journal-title":"eLife"},{"key":"472_CR52","doi-asserted-by":"crossref","unstructured":"Davis, C., Lalitha Sridhar, R., Chakraborty, S., Zawieja, D. & Moreno, M. Quantifying lymphatic endothelial cell morphological changes in response to fluid shear stress, cyclic strain, or combined stress and strain in vitro. FASEB J. 35, fasebj.2021.35.S1.03528 (2021).","DOI":"10.1096\/fasebj.2021.35.S1.03528"},{"key":"472_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.devcel.2011.12.020","volume":"22","author":"A Sabine","year":"2012","unstructured":"Sabine, A. et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control Connexin37 and calcineurin during lymphatic-valve formation. Dev. Cell 22, 430\u2013445 (2012).","journal-title":"Dev. Cell"},{"key":"472_CR54","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1172\/JCI80454","volume":"125","author":"A Sabine","year":"2015","unstructured":"Sabine, A. et al. FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature. J. Clin. Investig. 125, 3861\u20133877 (2015).","journal-title":"J. Clin. Investig."},{"key":"472_CR55","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cmet.2017.07.020","volume":"26","author":"N Escobedo","year":"2017","unstructured":"Escobedo, N. & Oliver, G. The lymphatic vasculature: its role in adipose metabolism and obesity. Cell Metab. 26, 598\u2013609 (2017).","journal-title":"Cell Metab."},{"key":"472_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1228456","volume":"339","author":"M Weber","year":"2013","unstructured":"Weber, M. et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339, 328\u2013332 (2013).","journal-title":"Science"},{"key":"472_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8139","volume":"6","author":"HR Hampton","year":"2015","unstructured":"Hampton, H. R., Bailey, J., Tomura, M., Brink, R. & Chtanova, T. Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes. Nat. Commun. 6, 7139 (2015).","journal-title":"Nat. Commun."},{"key":"472_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2353\/ajpath.2007.070225","volume":"171","author":"K Kabashima","year":"2007","unstructured":"Kabashima, K. et al. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171, 1249\u20131257 (2007).","journal-title":"Am. J. Pathol."},{"key":"472_CR59","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.4049\/jimmunol.1301791","volume":"193","author":"CV Gorlino","year":"2014","unstructured":"Gorlino, C. V. et al. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. J. Immunol. 193, 1966\u20131974 (2014).","journal-title":"J. Immunol."},{"key":"472_CR60","doi-asserted-by":"publisher","first-page":"8014","DOI":"10.1074\/jbc.M115.708305","volume":"291","author":"W Lawrance","year":"2016","unstructured":"Lawrance, W., Banerji, S., Day, A. J., Bhattacharjee, S. & Jackson, D. G. Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization. J. Biol. Chem. 291, 8014\u20138030 (2016).","journal-title":"J. Biol. Chem."},{"key":"472_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri.2016.116","volume":"17","author":"T Worbs","year":"2017","unstructured":"Worbs, T., Hammerschmidt, S. I. & F\u00f6rster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17, 30\u201348 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"472_CR62","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/cells10051269","volume":"10","author":"J Arasa","year":"2021","unstructured":"Arasa, J., Collado-Diaz, V. & Halin, C. Structure and immune function of afferent lymphatics and their mechanistic contribution to dendritic cell and T cell trafficking. Cells 10, 1269 (2021).","journal-title":"Cells"},{"key":"472_CR63","doi-asserted-by":"publisher","first-page":"a041186","DOI":"10.1101\/cshperspect.a041186","volume":"12","author":"A Bauer","year":"2022","unstructured":"Bauer, A., Tatliadim, H. & Halin, C. Leukocyte trafficking in lymphatic vessels. Cold Spring Harb. Perspect. Med. 12, a041186 (2022).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"472_CR64","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.4049\/jimmunol.1000568","volume":"185","author":"A Rathinasamy","year":"2010","unstructured":"Rathinasamy, A., Czeloth, N., Pabst, O., F\u00f6rster, R. & Bernhardt, G. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J. Immunol. 185, 4072\u20134081 (2010).","journal-title":"J. Immunol."},{"key":"472_CR65","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.immuni.2014.07.013","volume":"41","author":"AL St. John","year":"2014","unstructured":"St. John, A. L. et al. S1P-dependent trafficking of intracellular yersinia pestis through lymph nodes establishes buboes and systemic infection. Immunity 41, 440\u2013450 (2014).","journal-title":"Immunity"},{"key":"472_CR66","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.4049\/jimmunol.175.5.2960","volume":"175","author":"N Czeloth","year":"2005","unstructured":"Czeloth, N., Bernhardt, G., Hofmann, F., Genth, H. & F\u00f6rster, R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 175, 2960\u20132967 (2005).","journal-title":"J. Immunol."},{"key":"472_CR67","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1182\/blood-2005-03-1288","volume":"106","author":"C Cao","year":"2005","unstructured":"Cao, C., Lawrence, D. A., Strickland, D. K. & Zhang, L. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106, 3234\u20133241 (2005).","journal-title":"Blood"},{"key":"472_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1189\/jlb.1HI0415-149R","volume":"98","author":"DA Rigby","year":"2015","unstructured":"Rigby, D. A., Ferguson, D. J. P., Johnson, L. A. & Jackson, D. G. Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction. J. Leukoc. Biol. 98, 897\u2013912 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"472_CR69","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20051759","volume":"203","author":"LA Johnson","year":"2006","unstructured":"Johnson, L. A. et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203, 2763\u20132777 (2006).","journal-title":"J. Exp. Med."},{"key":"472_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature06887","volume":"453","author":"T L\u00e4mmermann","year":"2008","unstructured":"L\u00e4mmermann, T. et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51\u201355 (2008).","journal-title":"Nature"},{"key":"472_CR71","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1182\/blood-2013-01-478206","volume":"122","author":"EL Gautier","year":"2013","unstructured":"Gautier, E. L., Ivanov, S., Lesnik, P. & Randolph, G. J. Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood 122, 2714\u20132722 (2013).","journal-title":"Blood"},{"key":"472_CR72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10456-013-9404-3","volume":"17","author":"D Aebischer","year":"2014","unstructured":"Aebischer, D., Iolyeva, M. & Halin, C. The inflammatory response of lymphatic endothelium. Angiogenesis 17, 383\u2013393 (2014).","journal-title":"Angiogenesis"},{"key":"472_CR73","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1002\/eji.200939896","volume":"39","author":"M Karikoski","year":"2009","unstructured":"Karikoski, M. et al. Clever-1\/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. Eur. J. Immunol. 39, 3477\u20133487 (2009).","journal-title":"Eur. J. Immunol."},{"key":"472_CR74","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni1238","volume":"6","author":"GF Debes","year":"2005","unstructured":"Debes, G. F. et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6, 889\u2013894 (2005).","journal-title":"Nat. Immunol."},{"key":"472_CR75","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni1240","volume":"6","author":"SK Bromley","year":"2005","unstructured":"Bromley, S. K., Thomas, S. Y. & Luster, A. D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6, 895\u2013901 (2005).","journal-title":"Nat. Immunol."},{"key":"472_CR76","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.4049\/jimmunol.1500626","volume":"195","author":"D G\u00f3mez","year":"2015","unstructured":"G\u00f3mez, D., Diehl, M. C., Crosby, E. J., Weinkopff, T. & Debes, G. F. Effector T cell egress via afferent lymph modulates local tissue inflammation. J. Immunol. 195, 3531\u20133536 (2015).","journal-title":"J. Immunol."},{"key":"472_CR77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.it.2012.02.007","volume":"33","author":"R F\u00f6rster","year":"2012","unstructured":"F\u00f6rster, R., Braun, A. & Worbs, T. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol. 33, 271\u2013280 (2012).","journal-title":"Trends Immunol."},{"key":"472_CR78","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.4049\/jimmunol.1000676","volume":"185","author":"MN Brown","year":"2010","unstructured":"Brown, M. N. et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 185, 4873\u20134882 (2010).","journal-title":"J. Immunol."},{"key":"472_CR79","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","volume":"30","author":"JG Cyster","year":"2012","unstructured":"Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69\u201394 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"472_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/ni1534","volume":"9","author":"LG Ledgerwood","year":"2008","unstructured":"Ledgerwood, L. G. et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9, 42\u201353 (2008).","journal-title":"Nat. Immunol."},{"key":"472_CR81","doi-asserted-by":"crossref","unstructured":"Hunter, M. C. et al. Dendritic cells and T cells interact within murine afferent lymphatic capillaries. Front. Immunol. 10, 2019(2019).","DOI":"10.3389\/fimmu.2019.00520"},{"key":"472_CR82","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fimmu.2019.00598","volume":"10","author":"AJ Hayes","year":"2019","unstructured":"Hayes, A. J. et al. Spatiotemporal modeling of the key migratory events during the initiation of adaptive immunity. Front. Immunol. 10, 598 (2019).","journal-title":"Front. Immunol."},{"key":"472_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1084\/jem.20091619","volume":"207","author":"THM Pham","year":"2010","unstructured":"Pham, T. H. M. et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207, 17\u201327 (2010).","journal-title":"J. Exp. Med."},{"key":"472_CR84","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/416094a","volume":"416","author":"K Reif","year":"2002","unstructured":"Reif, K. et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416, 94\u201399 (2002).","journal-title":"Nature"},{"key":"472_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.20020201","volume":"196","author":"T Okada","year":"2002","unstructured":"Okada, T. et al. Chemokine requirements for b cell entry to lymph nodes and Peyer\u2019s patches. J. Exp. Med. 196, 65\u201375 (2002).","journal-title":"J. Exp. Med."},{"key":"472_CR86","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2008.12.018","volume":"30","author":"RK Sinha","year":"2009","unstructured":"Sinha, R. K., Park, C., Hwang, I.-Y., Davis, M. D. & Kehrl, J. H. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis. Immunity 30, 434\u2013446 (2009).","journal-title":"Immunity"},{"key":"472_CR87","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1172\/JCI73316","volume":"124","author":"CM Card","year":"2014","unstructured":"Card, C. M., Yu, S. S. & Swartz, M. A. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J. Clin. Investig. 124, 943\u2013952 (2014).","journal-title":"J. Clin. Investig."},{"key":"472_CR88","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.celrep.2012.01.005","volume":"1","author":"AW Lund","year":"2012","unstructured":"Lund, A. W. et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 1, 191\u2013199 (2012).","journal-title":"Cell Rep."},{"key":"472_CR89","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20092465","volume":"207","author":"JN Cohen","year":"2010","unstructured":"Cohen, J. N. et al. Lymph node\u2013resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207, 681\u2013688 (2010).","journal-title":"J. Exp. Med."},{"key":"472_CR90","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1182\/blood-2012-04-427013","volume":"120","author":"EF Tewalt","year":"2012","unstructured":"Tewalt, E. F. et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 120, 4772\u20134782 (2012).","journal-title":"Blood"},{"key":"472_CR91","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ni1427","volume":"8","author":"J-W Lee","year":"2007","unstructured":"Lee, J.-W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8, 181\u2013190 (2007).","journal-title":"Nat. Immunol."},{"key":"472_CR92","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1053\/j.gastro.2008.01.070","volume":"134","author":"FC Magnusson","year":"2008","unstructured":"Magnusson, F. C. et al. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology 134, 1028\u20131037 (2008).","journal-title":"Gastroenterology"},{"key":"472_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4989","volume":"5","author":"BA Tamburini","year":"2014","unstructured":"Tamburini, B. A., Burchill, M. A. & Kedl, R. M. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat. Commun. 5, 3989 (2014).","journal-title":"Nat. Commun."},{"key":"472_CR94","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund, A. W. et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J. Clin. Investig. 126, 3389\u20133402 (2016).","journal-title":"J. Clin. Investig."},{"key":"472_CR95","doi-asserted-by":"publisher","first-page":"e201800164","DOI":"10.26508\/lsa.201800164","volume":"1","author":"J Dubrot","year":"2018","unstructured":"Dubrot, J. et al. Absence of MHC-II expression by lymph node stromal cells results in autoimmunity. Life Sci. Alliance 1, e201800164 (2018).","journal-title":"Life Sci. Alliance"},{"key":"472_CR96","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fimmu.2019.01168","volume":"10","author":"HR Hampton","year":"2019","unstructured":"Hampton, H. R. & Chtanova, T. Lymphatic migration of immune cells. Front. Immunol. 10, 1168 (2019).","journal-title":"Front. Immunol."},{"key":"472_CR97","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10741-021-10188-5","volume":"27","author":"R-C Ji","year":"2022","unstructured":"Ji, R.-C. The role of lymphangiogenesis in cardiovascular diseases and heart transplantation. Heart Fail. Rev. 27, 1837\u20131856 (2022).","journal-title":"Heart Fail. Rev."},{"key":"472_CR98","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192\u2013198 (2001).","journal-title":"Nat. Med."},{"key":"472_CR99","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1182\/blood-2006-05-021758","volume":"109","author":"S Hirakawa","year":"2007","unstructured":"Hirakawa, S. et al. VEGF-C\u2013induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010\u20131017 (2007).","journal-title":"Blood"},{"key":"472_CR100","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn, N. E. et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell 185, 1924\u20131942.e23 (2022).","journal-title":"Cell"},{"key":"472_CR101","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garc\u00eda-Silva","year":"2021","unstructured":"Garc\u00eda-Silva, S. et al. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat. Cancer 2, 1387\u20131405 (2021).","journal-title":"Nat. Cancer"},{"key":"472_CR102","doi-asserted-by":"crossref","unstructured":"Bordry, N. et al. Lymphatic vessel density is associated with CD8\u2009+\u2009T cell infiltration and immunosuppressive factors in human melanoma. OncoImmunology e1462878 (2018).","DOI":"10.1080\/2162402X.2018.1462878"},{"key":"472_CR103","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat4758","volume":"4","author":"Q Ma","year":"2018","unstructured":"Ma, Q. et al. Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci. Adv. 4, eaat4758 (2018).","journal-title":"Sci. Adv."},{"key":"472_CR104","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker, S. A. et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 14, 159\u2013172 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"472_CR105","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota, S. J. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672\u2013682 (2001).","journal-title":"EMBO J."},{"key":"472_CR106","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1172\/JCI71606","volume":"124","author":"S Karaman","year":"2014","unstructured":"Karaman, S. & Detmar, M. Mechanisms of lymphatic metastasis. J. Clin. Investig. 124, 922\u2013928 (2014).","journal-title":"J. Clin. Investig."},{"key":"472_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54874-y","volume":"15","author":"W Piao","year":"2024","unstructured":"Piao, W. et al. Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling. Nat. Commun. 15, 10468 (2024).","journal-title":"Nat. Commun."},{"key":"472_CR108","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.20111627","volume":"210","author":"S Das","year":"2013","unstructured":"Das, S. et al. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J. Exp. Med. 210, 1509\u20131528 (2013).","journal-title":"J. Exp. Med."},{"key":"472_CR109","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","volume":"69","author":"A Issa","year":"2009","unstructured":"Issa, A., Le, T. X., Shoushtari, A. N., Shields, J. D. & Swartz, M. A. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell\u2013lymphatic cross-talk promote invasive phenotype. Cancer Res. 69, 349\u2013357 (2009).","journal-title":"Cancer Res."},{"key":"472_CR110","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1038\/sj.onc.1210267","volume":"26","author":"K Kawada","year":"2007","unstructured":"Kawada, K. et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 26, 4679\u20134688 (2007).","journal-title":"Oncogene"},{"key":"472_CR111","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.1158\/0008-5472.CAN-10-2591","volume":"70","author":"M Kim","year":"2010","unstructured":"Kim, M. et al. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 70, 10411\u201310421 (2010).","journal-title":"Cancer Res."},{"key":"472_CR112","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/genes11111309","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Wang, H., Xu, Z., Bai, Y. & Xu, L. Lymphatic metastasis of NSCLC involves chemotaxis effects of lymphatic endothelial cells through the CCR7\u2013CCL21 axis modulated by TNF-\u03b1. Genes 11, 1309 (2020).","journal-title":"Genes"},{"key":"472_CR113","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.ajpath.2019.12.004","volume":"190","author":"S Kumaravel","year":"2020","unstructured":"Kumaravel, S. et al. CXCL11-CXCR3 axis mediates tumor lymphatic cross talk and inflammation-induced tumor, promoting pathways in head and neck cancers. Am. J. Pathol. 190, 900\u2013915 (2020).","journal-title":"Am. J. Pathol."},{"key":"472_CR114","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2017.00066","volume":"8","author":"LC Dieterich","year":"2017","unstructured":"Dieterich, L. C. et al. Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation. Front. Immunol. 8, 66 (2017).","journal-title":"Front. Immunol."},{"key":"472_CR115","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1084\/jem.20180654","volume":"215","author":"RS Lane","year":"2018","unstructured":"Lane, R. S. et al. IFN\u03b3-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. J. Exp. Med. 215, 3057\u20133074 (2018).","journal-title":"J. Exp. Med."},{"key":"472_CR116","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41590-023-01443-y","volume":"24","author":"MM Steele","year":"2023","unstructured":"Steele, M. M. et al. T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nat. Immunol. 24, 664\u2013675 (2023).","journal-title":"Nat. Immunol."},{"key":"472_CR117","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/scitranslmed.aad6352","volume":"8","author":"B Mlecnik","year":"2016","unstructured":"Mlecnik, B. et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci. Transl. Med. 8, 66 (2016).","journal-title":"Sci. Transl. Med."},{"key":"472_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5420-z","volume":"19","author":"M Sha","year":"2019","unstructured":"Sha, M. et al. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer 19, 208 (2019).","journal-title":"BMC Cancer"},{"key":"472_CR119","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal4712","volume":"9","author":"M Fankhauser","year":"2017","unstructured":"Fankhauser, M. et al. Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Sci. Transl. Med. 9, eaal4712 (2017).","journal-title":"Sci. Transl. Med."},{"key":"472_CR120","doi-asserted-by":"publisher","first-page":"012","DOI":"10.1055\/s-0038-1635117","volume":"32","author":"A Greene","year":"2018","unstructured":"Greene, A. & Goss, J. Diagnosis and staging of lymphedema. Semin. Plast. Surg. 32, 012\u2013016 (2018).","journal-title":"Semin. Plast. Surg."},{"key":"472_CR121","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1056\/NEJMc1201684","volume":"366","author":"AK Greene","year":"2012","unstructured":"Greene, A. K., Grant, F. D. & Slavin, S. A. Lower-extremity lymphedema and elevated body-mass index. N. Engl. J. Med. 366, 2136\u20132137 (2012).","journal-title":"N. Engl. J. Med."},{"key":"472_CR122","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2019.00076","volume":"10","author":"Y Yuan","year":"2019","unstructured":"Yuan, Y., Arcucci, V., Levy, S. M. & Achen, M. G. Modulation of immunity by lymphatic dysfunction in lymphedema. Front. Immunol. 10, 76 (2019).","journal-title":"Front. Immunol."},{"key":"472_CR123","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2019.00470","volume":"10","author":"RP Kataru","year":"2019","unstructured":"Kataru, R. P. et al. Regulation of immune function by the lymphatic system in lymphedema. Front. Immunol. 10, 470 (2019).","journal-title":"Front. Immunol."},{"key":"472_CR124","doi-asserted-by":"publisher","first-page":"C709","DOI":"10.1152\/ajpcell.00284.2011","volume":"302","author":"JC Zampell","year":"2012","unstructured":"Zampell, J. C. et al. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. Am. J. Physiol. Cell Physiol. 302, C709\u2013C719 (2012).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"472_CR125","doi-asserted-by":"publisher","first-page":"H1065","DOI":"10.1152\/ajpheart.00598.2014","volume":"308","author":"S Ghanta","year":"2015","unstructured":"Ghanta, S. et al. Regulation of inflammation and fibrosis by macrophages in lymphedema. Am. J. Physiol. Heart Circ. Physiol. 308, H1065\u2013H1077 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"472_CR126","doi-asserted-by":"publisher","first-page":"18784","DOI":"10.1073\/pnas.1116152108","volume":"108","author":"S Liao","year":"2011","unstructured":"Liao, S. et al. Impaired lymphatic contraction associated with immunosuppression. Proc. Natl. Acad. Sci. USA 108, 18784\u201318789 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR127","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jid.2017.09.011","volume":"138","author":"GD Garc\u00eda Nores","year":"2018","unstructured":"Garc\u00eda Nores, G. D. et al. Regulatory T cells mediate local immunosuppression in lymphedema. J. Investig. Dermatol. 138, 325\u2013335 (2018).","journal-title":"J. Investig. Dermatol."},{"key":"472_CR128","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/lrb.2020.0061","volume":"19","author":"GA Cuadrado","year":"2021","unstructured":"Cuadrado, G. A., De Andrade, M. F. C., Ariga, S. K., De Lima, T. M. & Souza, H. P. Inflammation precedes fat deposition in an experimental model of lymphedema. Lymphat. Res. Biol. 19, 116\u2013125 (2021).","journal-title":"Lymphat. Res. Biol."},{"key":"472_CR129","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314\u2013321 (2008).","journal-title":"Nature"},{"key":"472_CR130","doi-asserted-by":"publisher","first-page":"tkae040","DOI":"10.1093\/burnst\/tkae040","volume":"12","author":"Y Jian","year":"2024","unstructured":"Jian, Y. et al. Lymphangiogenesis: novel strategies to promote cutaneous wound healing. Burns Trauma 12, tkae040 (2024).","journal-title":"Burns Trauma"},{"key":"472_CR131","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/biomedicines11030656","volume":"11","author":"F Ren\u00f2","year":"2023","unstructured":"Ren\u00f2, F. & Sabbatini, M. Breaking a vicious circle: lymphangiogenesis as a new therapeutic target in wound healing. Biomedicines 11, 656 (2023).","journal-title":"Biomedicines"},{"key":"472_CR132","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s11538-016-0205-x","volume":"78","author":"A Bianchi","year":"2016","unstructured":"Bianchi, A., Painter, K. J. & Sherratt, J. A. Spatio-temporal Models of Lymphangiogenesis in Wound Healing. Bull. Math. Biol. 78, 1904\u20131941 (2016).","journal-title":"Bull. Math. Biol."},{"key":"472_CR133","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela, T. & Alitalo, K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 140, 460\u2013476 (2010).","journal-title":"Cell"},{"key":"472_CR134","doi-asserted-by":"publisher","first-page":"H1402","DOI":"10.1152\/ajpheart.00038.2006","volume":"291","author":"JM Rutkowski","year":"2006","unstructured":"Rutkowski, J. M., Boardman, K. C. & Swartz, M. A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am. J. Physiol. Heart Circ. Physiol. 291, H1402\u2013H1410 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"472_CR135","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/cvr\/cvm094","volume":"78","author":"AV Benest","year":"2008","unstructured":"Benest, A. V., Harper, S. J., Herttuala, S. Y., Alitalo, K. & Bates, D. O. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovasc. Res. 78, 315\u2013323 (2008).","journal-title":"Cardiovasc. Res."},{"key":"472_CR136","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-021-00406-z","volume":"27","author":"J Zhou","year":"2021","unstructured":"Zhou, J., Wei, T. & He, Z. ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m6A modification to improve wound healing of diabetic foot ulcers. Mol. Med. 27, 146 (2021).","journal-title":"Mol. Med."},{"key":"472_CR137","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1172\/JCI136057","volume":"130","author":"W Li","year":"2020","unstructured":"Li, W. et al. Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance. J. Clin. Investig. 130, 6718\u20136727 (2020).","journal-title":"J. Clin. Investig."},{"key":"472_CR138","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/CIRCULATIONAHA.122.060799","volume":"147","author":"K Chen","year":"2023","unstructured":"Chen, K. et al. The effect of lymphangiogenesis in transplant arteriosclerosis. Circulation 147, 482\u2013497 (2023).","journal-title":"Circulation"},{"key":"472_CR139","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.3390\/cancers17193180","volume":"17","author":"R Yang","year":"2025","unstructured":"Yang, R., Hedberg, J., Montagano, J., Seals, M. & Puri, S. Oncolytic virus therapies in malignant gliomas: advances and clinical trials. Cancers 17, 3180 (2025).","journal-title":"Cancers"},{"key":"472_CR140","doi-asserted-by":"publisher","first-page":"1658357","DOI":"10.3389\/fmed.2025.1658357","volume":"12","author":"H He","year":"2025","unstructured":"He, H., Zhou, C., Xiong, J. & Fan, J. Novel applications of gene and cell therapies in the treatment of gynecological disorders. Front. Med. 12, 1658357 (2025).","journal-title":"Front. Med."},{"key":"472_CR141","doi-asserted-by":"publisher","first-page":"1678325","DOI":"10.3389\/fmed.2025.1678325","volume":"12","author":"V Kumar","year":"2025","unstructured":"Kumar, V. et al. AAV viral vectors as therapeutic interventions for inherited or non-inherited cardiac disorders: current aspects and future prospects. Front. Med. 12, 1678325 (2025).","journal-title":"Front. Med."},{"key":"472_CR142","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/01.RES.88.6.623","volume":"88","author":"B Enholm","year":"2001","unstructured":"Enholm, B. et al. Adenoviral expression of vascular endothelial growth factor-c induces lymphangiogenesis in the skin. Circ. Res. 88, 623\u2013629 (2001).","journal-title":"Circ. Res."},{"key":"472_CR143","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2353\/ajpath.2006.051251","volume":"169","author":"A Saaristo","year":"2006","unstructured":"Saaristo, A. et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169, 1080\u20131087 (2006).","journal-title":"Am. J. Pathol."},{"key":"472_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12792","volume":"30","author":"E Michalaki","year":"2023","unstructured":"Michalaki, E. et al. Lentiviral overexpression of VEGFC in transplanted MSCs leads to resolution of swelling in a mouse tail lymphedema model. Microcirculation 30, e12792 (2023).","journal-title":"Microcirculation"},{"key":"472_CR145","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1172\/JCI136164","volume":"130","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. Decreased lymphatic HIF-2\u03b1 accentuates lymphatic remodeling in lymphedema. J. Clin. Investig. 130, 5562\u20135575 (2020).","journal-title":"J. Clin. Investig."},{"key":"472_CR146","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1074\/jbc.273.12.6599","volume":"273","author":"V Joukov","year":"1998","unstructured":"Joukov, V. et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J. Biol. Chem. 273, 6599\u20136602 (1998).","journal-title":"J. Biol. Chem."},{"key":"472_CR147","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1172\/JCI79693","volume":"125","author":"Y Cui","year":"2015","unstructured":"Cui, Y. et al. Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection. J. Clin. Investig. 125, 4255\u20134268 (2015).","journal-title":"J. Clin. Investig."},{"key":"472_CR148","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2009.0002","volume":"7","author":"DP Jin","year":"2009","unstructured":"Jin, D. P., An, A., Liu, J., Nakamura, K. & Rockson, S. G. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat. Res. Biol. 7, 47\u201357 (2009).","journal-title":"Lymphat. Res. Biol."},{"key":"472_CR149","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"472_CR150","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1084\/jem.20100559","volume":"207","author":"R Huggenberger","year":"2010","unstructured":"Huggenberger, R. et al. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J. Exp. Med. 207, 2255\u20132269 (2010).","journal-title":"J. Exp. Med."},{"key":"472_CR151","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ygyno.2011.07.006","volume":"123","author":"N Chaudary","year":"2011","unstructured":"Chaudary, N., Milosevic, M. & Hill, R. P. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol. Oncol. 123, 393\u2013400 (2011).","journal-title":"Gynecol. Oncol."},{"key":"472_CR152","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1158\/0008-5472.CAN-18-0250","volume":"78","author":"KR Kampen","year":"2018","unstructured":"Kampen, K. R. et al. VEGFC antibody therapy drives differentiation of AML. Cancer Res. 78, 5940\u20135948 (2018).","journal-title":"Cancer Res."},{"key":"472_CR153","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCULATIONAHA.123.064181","volume":"148","author":"D Kim","year":"2023","unstructured":"Kim, D. et al. Abnormal lymphatic sphingosine-1-phosphate signaling aggravates lymphatic dysfunction and tissue inflammation. Circulation 148, 1231\u20131249 (2023).","journal-title":"Circulation"},{"key":"472_CR154","unstructured":"Circadian Technologies Ltd. A Phase I, Open Label, Dose Escalation Study of the VEGF-C Human Monoclonal Antibody VGX-100 Administered by Intravenous Infusion Alone and Co-Administered With Bevacizumab in Adult Subjects With Advanced or Metastatic Solid Tumors. https:\/\/clinicaltrials.gov\/study\/NCT01514123 (2020)."},{"key":"472_CR155","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1200\/jco.2014.32.15_suppl.2524","volume":"32","author":"GS Falchook","year":"2014","unstructured":"Falchook, G. S. et al. A first-in-human phase I study of VGX-100, a selective anti-VEGF-C antibody, alone and in combination with bevacizumab in patients with advanced solid tumors. JCO 32, 2524\u20132524 (2014).","journal-title":"JCO"},{"key":"472_CR156","doi-asserted-by":"publisher","first-page":"1800157","DOI":"10.1002\/adtp.201800157","volume":"2","author":"RS Oakes","year":"2019","unstructured":"Oakes, R. S., Froimchuk, E. & Jewell, C. M. Engineering biomaterials to direct innate immunity. Adv. Ther. 2, 1800157 (2019).","journal-title":"Adv. Ther."},{"key":"472_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/srep35182","volume":"6","author":"B-R Lee","year":"2016","unstructured":"Lee, B.-R. et al. Engineered human ferritin nanoparticles for direct delivery of tumor antigens to lymph node and cancer immunotherapy. Sci. Rep. 6, 35182 (2016).","journal-title":"Sci. Rep."},{"key":"472_CR158","doi-asserted-by":"publisher","first-page":"31780","DOI":"10.1021\/acsnano.4c06667","volume":"18","author":"MA Ackun-Farmmer","year":"2024","unstructured":"Ackun-Farmmer, M. A. et al. Engineered immune constructs alter antigen-specific immune tolerance and confer durable protection in myelin-driven autoimmunity. ACS Nano 18, 31780\u201331793 (2024).","journal-title":"ACS Nano"},{"key":"472_CR159","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.actbio.2024.12.039","volume":"193","author":"MA Farooq","year":"2025","unstructured":"Farooq, M. A., Johnston, A. P. R. & Trevaskis, N. L. Impact of nanoparticle properties on immune cell interactions in the lymph node. Acta Biomater. 193, 65\u201382 (2025).","journal-title":"Acta Biomater."},{"key":"472_CR160","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/jps.21970","volume":"99","author":"DA Rao","year":"2010","unstructured":"Rao, D. A., Forrest, M. L., Alani, A. W. G., Kwon, G. S. & Robinson, J. R. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. J. Pharm. Sci. 99, 2018\u20132031 (2010).","journal-title":"J. Pharm. Sci."},{"key":"472_CR161","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1016\/j.biomaterials.2007.03.022","volume":"28","author":"J Liu","year":"2007","unstructured":"Liu, J., Meisner, D., Kwong, E., Wu, X. Y. & Johnston, M. R. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA\u2013paclitaxel microspheres. Biomaterials 28, 3236\u20133244 (2007).","journal-title":"Biomaterials"},{"key":"472_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4097","volume":"5","author":"DLJ Thorek","year":"2014","unstructured":"Thorek, D. L. J. et al. Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET\/MRI nanoparticle. Nat. Commun. 5, 3097 (2014).","journal-title":"Nat. Commun."},{"key":"472_CR163","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1021\/acs.chemmater.4c00947","volume":"36","author":"CJ Bridgeman","year":"2024","unstructured":"Bridgeman, C. J. et al. Synthetic organic materials for targeting immunotherapies to lymph nodes. Chem. Mater. 36, 9031\u20139045 (2024).","journal-title":"Chem. Mater."},{"key":"472_CR164","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejpb.2021.09.004","volume":"172","author":"G Gracia","year":"2022","unstructured":"Gracia, G. et al. Association of a vaccine adjuvant with endogenous HDL increases lymph uptake and dendritic cell activation. Eur. J. Pharm. Biopharm. 172, 240\u2013252 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"472_CR165","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409563122","volume":"122","author":"SM Kapnick","year":"2025","unstructured":"Kapnick, S. M. et al. Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity. Proc. Natl. Acad. Sci. USA 122, e2409563122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR166","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.biomaterials.2012.12.003","volume":"34","author":"C Niu","year":"2013","unstructured":"Niu, C. et al. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US\/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 34, 2307\u20132317 (2013).","journal-title":"Biomaterials"},{"key":"472_CR167","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1021\/nn507433p","volume":"9","author":"R Qiao","year":"2015","unstructured":"Qiao, R. et al. Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles. ACS Nano 9, 2120\u20132129 (2015).","journal-title":"ACS Nano"},{"key":"472_CR168","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1021\/nn502975r","volume":"8","author":"D Muraoka","year":"2014","unstructured":"Muraoka, D. et al. Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. ACS Nano 8, 9209\u20139218 (2014).","journal-title":"ACS Nano"},{"key":"472_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123410","volume":"322","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. LNPs-mediated VEGF-C mRNA delivery promotes heart repair and attenuates inflammation by stimulating lymphangiogenesis post-myocardial infarction. Biomaterials 322, 123410 (2025).","journal-title":"Biomaterials"},{"key":"472_CR170","doi-asserted-by":"publisher","first-page":"13443","DOI":"10.3390\/ijms222413443","volume":"22","author":"N Clemente","year":"2021","unstructured":"Clemente, N. et al. Verteporfin-loaded mesoporous silica nanoparticles\u2019 topical applications inhibit mouse melanoma lymphangiogenesis and micrometastasis in vivo. IJMS 22, 13443 (2021).","journal-title":"IJMS"},{"key":"472_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/srep45459","volume":"7","author":"AO Oladipo","year":"2017","unstructured":"Oladipo, A. O. et al. A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy. Sci. Rep. 7, 45459 (2017).","journal-title":"Sci. Rep."},{"key":"472_CR172","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1245\/s10434-015-4594-0","volume":"22","author":"H Tsujimoto","year":"2015","unstructured":"Tsujimoto, H. et al. Theranostic photosensitive nanoparticles for lymph node metastasis of gastric cancer. Ann. Surg. Oncol. 22, 923\u2013928 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"472_CR173","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/pharmaceutics14020225","volume":"14","author":"H Xie","year":"2022","unstructured":"Xie, H. et al. Cerium-containing bioactive glasses promote in vitro lymphangiogenesis. Pharmaceutics 14, 225 (2022).","journal-title":"Pharmaceutics"},{"key":"472_CR174","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ultrasmedbio.2014.12.014","volume":"41","author":"S Kato","year":"2015","unstructured":"Kato, S. et al. Delivery of molecules to the lymph node via lymphatic vessels using ultrasound and nano\/microbubbles. Ultrasound Med. Biol. 41, 1411\u20131421 (2015).","journal-title":"Ultrasound Med. Biol."},{"key":"472_CR175","doi-asserted-by":"publisher","first-page":"115165","DOI":"10.1016\/j.colsurfb.2025.115165","volume":"257","author":"C Zhang","year":"2026","unstructured":"Zhang, C. et al. Compensatory mechanism of the injured lymphatic system: New insights from fluorescent nanoparticle assisted lymphangiography. Colloids Surf. B Biointerfaces 257, 115165 (2026).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"472_CR176","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq0435","volume":"9","author":"LF Sestito","year":"2023","unstructured":"Sestito, L. F. et al. Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function. Sci. Adv. 9, eabq0435 (2023).","journal-title":"Sci. Adv."},{"key":"472_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/srep27407","volume":"6","author":"HS Park","year":"2016","unstructured":"Park, H. S. et al. Clear-cut observation of clearance of sustainable upconverting nanoparticles from lymphatic system of small living mice. Sci. Rep. 6, 27407 (2016).","journal-title":"Sci. Rep."},{"key":"472_CR178","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1021\/acs.bioconjchem.9b00144","volume":"30","author":"G Xu","year":"2019","unstructured":"Xu, G. et al. Long-distance tracing of the lymphatic system with a computed tomography\/fluorescence dual-modality nanoprobe for surveying tumor lymphatic metastasis. Bioconjugate Chem. 30, 1199\u20131209 (2019).","journal-title":"Bioconjugate Chem."},{"key":"472_CR179","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/nano11071700","volume":"11","author":"I-C Sun","year":"2021","unstructured":"Sun, I.-C. et al. Theragnostic glycol chitosan-conjugated gold nanoparticles for photoacoustic imaging of regional lymph nodes and delivering tumor antigen to lymph nodes. Nanomaterials 11, 1700 (2021).","journal-title":"Nanomaterials"},{"key":"472_CR180","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.7150\/thno.42114","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Gadolinium-doped Au@prussian blue nanoparticles as MR\/SERS bimodal agents for dendritic cell activating and tracking. Theranostics 10, 6061\u20136071 (2020).","journal-title":"Theranostics"},{"key":"472_CR181","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41536-024-00347-1","volume":"9","author":"M Dave","year":"2024","unstructured":"Dave, M. et al. MSCs mediate long-term efficacy in a Crohn\u2019s disease model by sustained anti-inflammatory macrophage programming via efferocytosis. npj Regen. Med. 9, 6 (2024).","journal-title":"npj Regen. Med."},{"key":"472_CR182","doi-asserted-by":"crossref","unstructured":"Saha, S., Graham, F., Knopp, J., Patzke, C. & Hanjaya-Putra, D. Robust differentiation of human pluripotent stem cells into lymphatic endothelial cells using transcription factors. Cells Tissues Organs 1\u201311 (2024).","DOI":"10.1159\/000539699"},{"key":"472_CR183","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3892\/ijmm.2016.2502","volume":"37","author":"Y Igarashi","year":"2016","unstructured":"Igarashi, Y. et al. VEGF-C and TGF-\u03b2 reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes. Int. J. Mol. Med. 37, 1005\u20131013 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"472_CR184","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.108.793208","volume":"119","author":"C Conrad","year":"2009","unstructured":"Conrad, C. et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 119, 281\u2013289 (2009).","journal-title":"Circulation"},{"key":"472_CR185","first-page":"21","volume":"5","author":"AJ Rufaihah","year":"2013","unstructured":"Rufaihah, A. J. et al. Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am. J. Transl. Res. 5, 21\u201335 (2013).","journal-title":"Am. J. Transl. Res."},{"key":"472_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/srep11019","volume":"5","author":"S-J Lee","year":"2015","unstructured":"Lee, S.-J. et al. Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. Sci. Rep. 5, 11019 (2015).","journal-title":"Sci. Rep."},{"key":"472_CR187","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.3390\/ijms21113885","volume":"21","author":"R Ogino","year":"2020","unstructured":"Ogino, R., Hayashida, K., Yamakawa, S. & Morita, E. Adipose-derived stem cells promote intussusceptive lymphangiogenesis by restricting dermal fibrosis in irradiated tissue of mice. IJMS 21, 3885 (2020).","journal-title":"IJMS"},{"key":"472_CR188","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PRS.0000000000006474","volume":"145","author":"T Dai","year":"2020","unstructured":"Dai, T. et al. The roles of podoplanin-positive\/podoplanin-negative cells from adipose-derived stem cells in lymphatic regeneration. Plast. Reconstr. Surg. 145, 420\u2013431 (2020).","journal-title":"Plast. Reconstr. Surg."},{"key":"472_CR189","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/rme.15.24","volume":"10","author":"S Yoshida","year":"2015","unstructured":"Yoshida, S. et al. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model. Regen. Med. 10, 549\u2013562 (2015).","journal-title":"Regen. Med."},{"key":"472_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/7626767","volume":"2023","author":"Y Asano","year":"2023","unstructured":"Asano, Y., Shimoda, H., Okano, D., Matsusaki, M. & Akashi, M. Lymphatic drainage-promoting effects by engraftment of artificial lymphatic vascular tissue based on human adipose tissue-derived mesenchymal stromal cells in mice. J. Tissue Eng. Regener. Med. 2023, 1\u201315 (2023).","journal-title":"J. Tissue Eng. Regener. Med."},{"key":"472_CR191","doi-asserted-by":"publisher","first-page":"2200464","DOI":"10.1002\/adhm.202200464","volume":"11","author":"W Jia","year":"2022","unstructured":"Jia, W., He, W., Wang, G., Goldman, J. & Zhao, F. Enhancement of lymphangiogenesis by human mesenchymal stem cell sheet. Adv. Healthc. Mater. 11, 2200464 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"472_CR192","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/jjco\/hyn090","volume":"38","author":"C Hou","year":"2008","unstructured":"Hou, C., Wu, X. & Jin, X. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Jpn. J. Clin. Oncol. 38, 670\u2013674 (2008).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"472_CR193","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/lrb.2017.0027","volume":"16","author":"AM Ismail","year":"2018","unstructured":"Ismail, A. M. et al. Stem cell therapy using bone marrow-derived mononuclear cells in treatment of lower limb lymphedema: a randomized controlled clinical trial. Lymphat. Res. Biol. 16, 270\u2013277 (2018).","journal-title":"Lymphat. Res. Biol."},{"key":"472_CR194","unstructured":"Maldonado, D. med G. E. M. Postoperative Lymphedema Treatment in Upper Extremities Following Axillary Lymphadenectomy by Transplanting Autologous Endothelial Progenitor Cells (EPC). https:\/\/clinicaltrials.gov\/study\/NCT01112189 (2011)."},{"key":"472_CR195","unstructured":"J\u00f8rgensen, M. G. Treatment of Breast Cancer-Related Lymphedema With Stem Cells and Fat Grafting. https:\/\/clinicaltrials.gov\/study\/NCT03776721 (2021)."},{"key":"472_CR196","unstructured":"Toyserkani, N. Treatment of Breast Cancer Related Lymphedema With Cell-Assisted Lipotransfer. https:\/\/clinicaltrials.gov\/study\/NCT02592213 (2020)."},{"key":"472_CR197","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00018-013-1460-8","volume":"71","author":"K Buttler","year":"2014","unstructured":"Buttler, K. et al. De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice. Cell Mol. Life Sci. 71, 1513\u20131527 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"472_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111816","volume":"388","author":"N Ahmadzadeh","year":"2020","unstructured":"Ahmadzadeh, N. et al. Human adipose-derived stem cells support lymphangiogenesis in vitro by secretion of lymphangiogenic factors. Exp. Cell Res. 388, 111816 (2020).","journal-title":"Exp. Cell Res."},{"key":"472_CR199","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12739","volume":"29","author":"H Yamada","year":"2022","unstructured":"Yamada, H. et al. Xenotransplantation of neonatal porcine bone marrow\u2013derived mesenchymal stem cells improves diabetic wound healing by promoting angiogenesis and lymphangiogenesis. Xenotransplantation 29, e12739 (2022).","journal-title":"Xenotransplantation"},{"key":"472_CR200","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000492851","volume":"49","author":"X Wang","year":"2018","unstructured":"Wang, X., Wang, H., Cao, J. & Ye, C. Exosomes from adipose-derived stem cells promotes VEGF-C-dependent lymphangiogenesis by regulating miRNA-132\/TGF-\u03b2 pathway. Cell Physiol. Biochem. 49, 160\u2013171 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"472_CR201","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1111\/jcmm.13590","volume":"22","author":"JW Robering","year":"2018","unstructured":"Robering, J. W. et al. Mesenchymal stem cells promote lymphangiogenic properties of lymphatic endothelial cells. J. Cell Mol. Med. 22, 3740\u20133750 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"472_CR202","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221107536","volume":"31","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Extracellular vesicles derived from hypoxia-conditioned adipose-derived mesenchymal stem cells enhance lymphangiogenesis. Cell Transpl. 31, 09636897221107536 (2022).","journal-title":"Cell Transpl."},{"key":"472_CR203","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.RES.0000065621.69843.49","volume":"92","author":"KC Boardman","year":"2003","unstructured":"Boardman, K. C. & Swartz, M. A. Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92, 801\u2013808 (2003).","journal-title":"Circ. Res."},{"key":"472_CR204","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/bit.21185","volume":"96","author":"CE Helm","year":"2007","unstructured":"Helm, C. E., Zisch, A. & Swartz, M. A. Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotech. Bioeng. 96, 167\u2013176 (2007).","journal-title":"Biotech. Bioeng."},{"key":"472_CR205","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101931118","volume":"118","author":"S Landau","year":"2021","unstructured":"Landau, S. et al. Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networks. Proc. Natl. Acad. Sci. USA 118, e2101931118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"472_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03959-6","volume":"9","author":"M Frye","year":"2018","unstructured":"Frye, M. et al. Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program. Nat. Commun. 9, 1511 (2018).","journal-title":"Nat. Commun."},{"key":"472_CR207","doi-asserted-by":"crossref","unstructured":"Qin, Z. et al. Matrix stiffness of GelMA hydrogels regulates lymphatic endothelial cells toward enhanced lymphangiogenesis. ACS Appl. Mater. Interfaces acsami.4c11767 (2024).","DOI":"10.1021\/acsami.4c11767"},{"key":"472_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121483","volume":"284","author":"JST Hooks","year":"2022","unstructured":"Hooks, J. S. T. et al. Synthetic hydrogels engineered to promote collecting lymphatic vessel sprouting. Biomaterials 284, 121483 (2022).","journal-title":"Biomaterials"},{"key":"472_CR209","doi-asserted-by":"publisher","first-page":"58181","DOI":"10.1021\/acsami.3c12514","volume":"15","author":"F Fan","year":"2023","unstructured":"Fan, F. et al. Hyaluronic acid hydrogels with phototunable supramolecular cross-linking for spatially controlled lymphatic tube formation. ACS Appl. Mater. Interfaces 15, 58181\u201358195 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"472_CR210","doi-asserted-by":"crossref","unstructured":"Alderfer, L., Russo, E., Archilla, A., Coe, B. & Hanjaya-Putra, D. Matrix stiffness primes lymphatic tube formation directed by vascular endothelial growth factor-C. FASEB J. 35, e21498 (2021).","DOI":"10.1096\/fj.202002426RR"},{"key":"472_CR211","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s42003-024-06935-7","volume":"7","author":"L Alderfer","year":"2024","unstructured":"Alderfer, L. et al. Multi-parameter tunable synthetic matrix for engineering lymphatic vessels. Commun. Biol. 7, 1262 (2024).","journal-title":"Commun. Biol."},{"key":"472_CR212","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.actbio.2010.10.016","volume":"7","author":"EM Bouta","year":"2011","unstructured":"Bouta, E. M. et al. Biomaterial guides for lymphatic endothelial cell alignment and migration. Acta Biomater. 7, 1104\u20131113 (2011).","journal-title":"Acta Biomater."},{"key":"472_CR213","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biomaterials.2016.05.040","volume":"102","author":"C Hadamitzky","year":"2016","unstructured":"Hadamitzky, C. et al. Aligned nanofibrillar collagen scaffolds \u2013 Guiding lymphangiogenesis for treatment of acquired lymphedema. Biomaterials 102, 259\u2013267 (2016).","journal-title":"Biomaterials"},{"key":"472_CR214","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biomaterials.2015.11.027","volume":"78","author":"L Gibot","year":"2016","unstructured":"Gibot, L. et al. Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials 78, 129\u2013139 (2016).","journal-title":"Biomaterials"},{"key":"472_CR215","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jconrel.2024.07.068","volume":"373","author":"M Jia","year":"2024","unstructured":"Jia, M., Zhou, X., Li, P. & Zhang, S. An injectable biomimetic hydrogel adapting brain tissue mechanical strength for postoperative treatment of glioblastoma without anti-tumor drugs participation. J. Control. Release 373, 699\u2013712 (2024).","journal-title":"J. Control. Release"},{"key":"472_CR216","doi-asserted-by":"publisher","first-page":"849831","DOI":"10.3389\/fbioe.2022.849831","volume":"10","author":"F Xu","year":"2022","unstructured":"Xu, F. et al. Hydrogels for tissue engineering: addressing key design needs toward clinical translation. Front. Bioeng. Biotechnol. 10, 849831 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"472_CR217","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biomaterials.2017.03.033","volume":"131","author":"E G\u00fc\u00e7","year":"2017","unstructured":"G\u00fc\u00e7, E. et al. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials 131, 160\u2013175 (2017).","journal-title":"Biomaterials"},{"key":"472_CR218","doi-asserted-by":"publisher","first-page":"221ra14","DOI":"10.1126\/scitranslmed.3006894","volume":"6","author":"D Marino","year":"2014","unstructured":"Marino, D., Luginb\u00fchl, J., Scola, S., Meuli, M. & Reichmann, E. Bioengineering dermo-epidermal skin grafts with blood and lymphatic capillaries. Sci. Transl. Med. 6, 221ra14 (2014).","journal-title":"Sci. Transl. Med."},{"key":"472_CR219","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1016\/j.biomaterials.2011.02.051","volume":"32","author":"JH Hwang","year":"2011","unstructured":"Hwang, J. H. et al. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 32, 4415\u20134423 (2011).","journal-title":"Biomaterials"},{"key":"472_CR220","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fbioe.2017.00025","volume":"5","author":"L Knezevic","year":"2017","unstructured":"Knezevic, L. et al. Engineering blood and lymphatic microvascular networks in fibrin matrices. Front. Bioeng. Biotechnol. 5, 25 (2017).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"472_CR221","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1016\/j.biomaterials.2011.02.029","volume":"32","author":"SL Bellis","year":"2011","unstructured":"Bellis, S. L. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 32, 4205\u20134210 (2011).","journal-title":"Biomaterials"},{"key":"472_CR222","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3920","volume":"9","author":"W Tian","year":"2017","unstructured":"Tian, W. et al. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci. Transl. Med. 9, eaal3920 (2017).","journal-title":"Sci. Transl. Med."},{"key":"472_CR223","unstructured":"Eiger BioPharmaceuticals. Ubenimex in Adult Patients With Lymphedema of The Lower Limb: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA). https:\/\/clinicaltrials.gov\/study\/NCT02700529 (2022)."},{"key":"472_CR224","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jim.2006.01.022","volume":"312","author":"W Van Den Broeck","year":"2006","unstructured":"Van Den Broeck, W., Derore, A. & Simoens, P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB\/cAnNCrl mice. J. Immunol. Methods 312, 12\u201319 (2006).","journal-title":"J. Immunol. Methods"},{"key":"472_CR225","doi-asserted-by":"crossref","unstructured":"Weiler, M. J. A novel mouse tail lymphedema model for observing lymphatic pump failure during lymphedema development. Sci. Rep. 9, 10405 (2019).","DOI":"10.1038\/s41598-019-46797-2"},{"key":"472_CR226","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1021\/acsbiomaterials.8b00252","volume":"5","author":"Y Chandorkar","year":"2019","unstructured":"Chandorkar, Y., K, R. & Basu, B. The foreign body response demystified. ACS Biomater. Sci. Eng. 5, 19\u201344 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"472_CR227","doi-asserted-by":"crossref","unstructured":"Gonzalez-Simon, A. L. & Eniola-Adefeso, O. Host response to biomaterials. In Engineering Biomaterials for Regenerative Medicine (ed. Bhatia, S. K.) 143\u2013159 (Springer New York, 2012).","DOI":"10.1007\/978-1-4614-1080-5_6"},{"key":"472_CR228","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1158\/0008-5472.CAN-19-1932","volume":"80","author":"RS Oakes","year":"2020","unstructured":"Oakes, R. S. et al. Metastatic conditioning of myeloid cells at a subcutaneous synthetic niche reflects disease progression and predicts therapeutic outcomes. Cancer Res. 80, 602\u2013612 (2020).","journal-title":"Cancer Res."},{"key":"472_CR229","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1158\/0008-5472.CAN-20-0079","volume":"80","author":"AH Morris","year":"2020","unstructured":"Morris, A. H. et al. Engineered niches to analyze mechanisms of metastasis and guide precision medicine. Cancer Res. 80, 3786\u20133794 (2020).","journal-title":"Cancer Res."},{"key":"472_CR230","doi-asserted-by":"publisher","DOI":"10.1002\/imed.1052","volume":"4","author":"RM Raghani","year":"2024","unstructured":"Raghani, R. M. et al. Engineered immunologic niche monitors checkpoint blockade response and probes mechanisms of resistance. ImmunoMedicine 4, e1052 (2024).","journal-title":"ImmunoMedicine"},{"key":"472_CR231","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1002\/bit.28824","volume":"121","author":"JL King","year":"2024","unstructured":"King, J. L. et al. Polymer scaffolds delineate healthy from diseased states at sites distal from the pancreas in two models of type 1 diabetes. Biotech. Bioeng. 121, 3600\u20133613 (2024).","journal-title":"Biotech. Bioeng."},{"key":"472_CR232","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk6178","volume":"10","author":"RR Urie","year":"2024","unstructured":"Urie, R. R. et al. Biomarkers from subcutaneous engineered tissues predict acute rejection of organ allografts. Sci. Adv. 10, eadk6178 (2024).","journal-title":"Sci. Adv."},{"key":"472_CR233","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/lrb.2009.0007","volume":"7","author":"DC Zawieja","year":"2009","unstructured":"Zawieja, D. C. Contractile physiology of lymphatics. Lymphat. Res. Biol. 7, 87\u201396 (2009).","journal-title":"Lymphat. Res. Biol."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00472-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00472-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00472-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:02:24Z","timestamp":1784764944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00472-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":233,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1038\/s41536-026-00472-z","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.S.O. is an employee of the VA Maryland Health Care System. The views reported in this paper do not reflect the views of the Department of Veterans Affairs or the United States Government.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"33"}}